Showing results (2711-2720 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|March 12, 2013
Novel, small molecule induced GABA-hATSCs for targeting of neuropathic painMin Jee, Young Im, Jee I N Choi, et al.Human Gene Therapy|April 11, 2013
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomesBarbara K Smith, Shelley W Collins, Thomas J Conlon, et al.Human Gene Therapy|December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosisSanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.Human Gene Therapy|May 2, 2012
Efficacy of codelivery of dual AAV2/5 vectors in the murine retina and hippocampusArpad Palfi, Naomi Chadderton, Alex G McKee, et al.Human Gene Therapy|December 1, 2012
Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8Rita Ferla, Thomas O'Malley, Roberto Calcedo, et al.Human Gene Therapy|December 5, 2013
Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII miceLorena Ariza, Lydia Giménez-Llort, Aurélie Cubizolle, et al.Human Gene Therapy|November 7, 2013
Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic miceTaeyoung Koo, Linda Popplewell, Takis Athanasopoulos, et al.Human Gene Therapy|October 30, 2013
Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applicationsMichael G Katz, Anthony S Fargnoli, Richard D Williams, et al.Human Gene Therapy|October 30, 2013
Adeno-associated virus-mediated gene therapy for metabolic myopathyCathryn S Mah, Meghan S Soustek, A Gary Todd, et al.Human Gene Therapy|October 9, 2013
[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancerAnniina Koski, Helena Ahtinen, Heidi Liljenback, et al.Pageof 414